Efficacy of nivolumab + ipilimumab ± chemotherapy versus pembrolizumab + chemotherapy in patients with PD-L1-negative non-small cell lung cancer (START001 PART-B): a multicenter retrospective observational study
In patients with PD-L1-negative NSCLC, the efficacy of NI and NICT was not superior to that of PCT. Thus, we concluded that PCT could be a favorable treatment option for this patient population.
Authors
- Hirotaka Nishikiori (ORCID: https://orcid.org/0000-0002-0573-9344)
- Yuichiro Asai
- Makoto Shioya
- Yuta Sudo (ORCID: https://orcid.org/0000-0002-9713-339X)
- Yusuke Tanaka (ORCID: https://orcid.org/0000-0001-9301-437X)
- Osamu Honjo
- Yutaro Nagano
- Hirofumi Chiba (ORCID: https://orcid.org/0000-0002-7033-3084)
- Masahiro Yanagi (ORCID: https://orcid.org/0000-0002-1851-4160)
- Toshiyuki Sumi (ORCID: https://orcid.org/0000-0002-2540-5878)
- Masami Yamazoe
- Sayaka Kudo
- Tatsuru Ishikawa
- Midori Hashimoto
- Keiki Yokoo (ORCID: https://orcid.org/0009-0008-8576-4750)
- Shun Kondo
- Mitsuo Otsuka (ORCID: https://orcid.org/0000-0003-2324-2662)
- Yasuko Fukataki
- Mamoru Takahashi
- Shiro Hinotsu (ORCID: https://orcid.org/0009-0001-3111-695X)
- Hayato Yabe
Institutions
- Sapporo Medical University (JP)
- Akebono (Japan) (JP)
- NTT Medical Center (JP)
- Muroran Institute of Technology (JP)
- Otaru Municipal Hospital (JP)
- Tonan Hospital (JP)
- Sapporo Minami Hospital (JP)
- Sapporo Kosei General Hospital (JP)
- Japan Community Healthcare Organization (JP)
- Japanese Red Cross Asahikawa Hospital (JP)
- Teine Keijinkai Hospital (JP)
- Hakodate National Hospital (JP)
- Kushiro City General Hospital (JP)
- Data Management (Italy) (IT)
Publication Details
- Journal
- Japanese Journal of Clinical Oncology
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1093/jjco/hyaf073
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 2.09